Clinical Trials Directory

Trials / Sponsors / Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc.

Industry · 13 registered clinical trials1 currently recruiting.

StatusTrialPhaseStarted
RecruitingRegistry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrop
Duchenne Muscular Dystrophy
2024-09-25
TerminatedLong Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3
Spinal Muscular Atrophy Type 3
Phase 22019-03-07
CompletedControlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients
Muscular Atrophy, Spinal
Phase 22019-01-21
TerminatedLong Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravi
Myasthenia Gravis, MuSK, AChR Myasthenia Gravis
Phase 32018-06-11
CompletedStudy to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Myasthenia Gravis, Generalized
Phase 32018-04-18
CompletedPhase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)
Lambert-Eaton Myasthenic Syndrome
Phase 32016-11-01
CompletedAmifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes
Myasthenic Syndromes, Congenital
Phase 32016-01-01
CompletedA Safety, Tolerability and Pharmacokinetic Study of CPP-115
Cocaine Dependency
Phase 12011-12-01
CompletedA Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
Lambert Eaton Myasthenic Syndrome
Phase 32011-06-01
CompletedVigabatrin for the Treatment of Cocaine Dependency
Cocaine Addiction, Cocaine Dependence
Phase 2 / Phase 32011-01-01
TerminatedSafety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence
Methamphetamine Dependence
Phase 22008-07-01
CompletedVigabatrin for Treatment of Cocaine Dependence
Cocaine Dependence
Phase 22008-01-01
Approved For MarketingExpanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myastheni
Congenital Myasthenic Syndrome, Lambert-Eaton Myasthenic Syndrome, Nystagmus, Acquired